An effort to find new uses for drugs that have failed in clinical trials may offer hope for Alzheimer’s patients, a top U.S. health research scientist said.
Butamax Advanced Biofuels LLC asked the U.S. Patent and Trademark Office to reexamine a disputed patent owned by Gevo Inc., the U.S. biotechnology company backed by the oil refiner Total SA and the specialty chemicals maker Lanxess AG.
Research using human embryonic stem- cell lines approved under President Barack Obama is accelerating, boosting a scientific field that’s been dogged by legal and political threats.
"If we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would've gone through clinical trials and would have been ready."
- Francis Collins on Oct 13, 2014